Skip to content

Identifying Terpenoid- and Carotenoid-modifying Enzymes in the Human Gut

Phage-Enabled Mining of Gut Metagenomes for Terpenoid and Carotenoid Metabolism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07589166
Acronym
NCState
Enrollment
40
Registered
2026-05-15
Start date
2025-09-09
Completion date
2026-03-01
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotenoid Modifying Enzymes, Terpene Synthases

Brief summary

In this study, the investigators will collect fecal samples from healthy adults. The investigators will extract DNA from these fecal samples and use microbiological techniques to determine whether this DNA encodes enzymes that can react with certain chemicals called terpenoids and carotenoids. The investigators will additionally collect dietary information via a questionnaire.

Interventions

OTHERNo Intervention: Observational Cohort

No intervention

Sponsors

North Carolina State University
Lead SponsorOTHER
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body Mass index \<25

Exclusion criteria

* Pregnant * Taken antibiotics or antifungals in the past 3 months * Taken probiotic supplements in the past 3 months * Diarrhea in the past month

Design outcomes

Primary

MeasureTime frameDescription
Number of unique gut metagenomic enzymes with carotenoid-modifying activities for each participant.Day 1Subjects' fecal metagenomic DNA will be extracted from their fecal sample, and random fragments of this metagenomic DNA will be inserted into an E. coli expression vector. This vector library will be transformed into an E. coli strain that will change color if a carotenoid-modifying gene is present. We expect to obtain about one million E. coli clones per participant. These clones will be spread on agar plates, and the colonies exhibiting different colors will be recovered and sequenced. The sequences of each participant will be collected and annotated to determine putative carotenoid-modifying enzymes, and the number of unique enzymes will be saved.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026